Clin2
NCT07738614Possibly a fitRecruiting

Testing an investigational weight loss medicine for adults with overweight or obesity

ObesityOverweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
56 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have a body mass index (BMI) between 27 and 45.
  • Your weight has been stable (less than 5% change) for the last 3 months.
  • You do not have type 1 or type 2 diabetes, and your blood sugar levels are below the diabetes range.
  • You have not recently taken a GLP-1 medicine (like semaglutide) or similar weight loss drugs within the past 60 days.
  • You do not have a history of major depression or other severe psychiatric problems in the last 2 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07665879Recruiting· Phase 1
Study of an experimental drug for people with overweight or obesity

This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.

Neuss
NCT07321886Recruiting· Phase 3
Study of eloralintide for people with obesity or overweight

This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.

Tuscaloosa, Alabama
NCT07282600Recruiting· Phase 3
Study of eloralintide for type 2 diabetes and weight

This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.

Birmingham, Alabama
NCT07392190Recruiting· Phase 3
Study of eloralintide for people with persistent obesity

This trial tests if adding eloralintide helps people who are still obese or overweight while taking weekly incretin therapy. It aims to support additional weight loss for those who haven't reached their goals.

Birmingham, Alabama
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.